RecallHawk
Class II Recall

Omnipod 5 Automated Insulin Delivery System

Insulet Corporation

Summary

The FDA issued a Class II for Omnipod 5 Automated Insulin Delivery System by Insulet Corporation. Reason: An error message was received when using the Omnipod 5 App on compatible smartphones that prevented phone control users from controlling the Omnipod 5.

Details

Source

Device Recall

External ID

Z-2618-2023

Action Date

2023-09-27

Status

Ongoing

Category

device

Product Description

Omnipod 5 Automated Insulin Delivery System

Lot/Code Info: PT-000559 Omnipod 5 App; all versions of software installed UDI-DI: 10385081120302

Quantity Affected: 11,016 users

Reason for Recall

An error message was received when using the Omnipod 5 App on compatible smartphones that prevented phone control users from controlling the Omnipod 5 Automated Insulin Delivery System from their Omnipod 5 App which may cause a delay in therapy. To reduce the volume of inquiries Insulet was receiving from customers, an email was sent to all phone control users and the cause of the error message was resolved by reverting to prior certificates on the Insulet cloud to secure communications between the Omnipod 5 App sotware and the Insulet Cloud. This issue was limited to only certain compatible Android smartphones and did not affect the Omnipod 5 Pods or the dedicated locked-down Controller provided by Insulet. All other Omnipod 5 users were still able to manage their insulin with the device without use of the smartphone app and affected users were able to switch to the locked-down control provided to all users when they initiated the device during the time the App was unavailable to them. Further, the Omnipod itself continued to deliver insulin as per its pre-programmed settings so although affected users who did not have the locked-down controller readily available may not have been able to command insulin boluses during this time, they continued to receive basal insulin without interruption. Lastly, users of the Omnipod 5 were advised during training to always have backup supplies ready in the event of a device malfunction which would include alternative means to deliver insulin subcutaneously until the issue is resolved to minimize disruption to their insulin regimen. There were 2,168 complaints received out of 7,838 users with the Android compatible smartphones affected and 9 MDRs were submitted, however, there were no serious injuries reported or reports of erroneous results as the primary issue was a delay in therapy. This defect cannot cause false results that could negatively impact patients.

Distribution

Distribution throughout the US

Type: Voluntary: Firm initiated

Recall Initiated: 2023-02-28

Company

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 195 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Insulet Corporation has 17 FDA actions in our database, including 7 recalls and 10 clearances.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Insulet Corporation) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Insulet Corporation have FDA actions?

Insulet Corporation has 17 FDA actions in our database, including 7 recalls and 10 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-2618-2023" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions